Home › NDC Lookup › RxCUI directory › RxCUI 1012465

Dantrolene sodium 0.333 MG/ML Injectable Solution [Revonto] — RxCUI 1012465

RxNorm drug concept · Semantic branded drug
RxCUI 1012465 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1012465
Official nameDantrolene sodium 0.333 MG/ML Injectable Solution [Revonto]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRevonto 0.333 MG/ML Injectable Solution
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dantrolene: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dantrolene is used for two main things. If you're taking the capsules (Dantrium or Dantrolene Sodium), it's most likely to help control muscle stiffness and spasms caused by condit...
  • The most serious risk is liver damage. Watch for yellowing of your skin or the whites of your eyes, very dark urine, persistent nausea, or pain in the upper right side of your abdo...
  • What are the most important side effects I should watch for?
  • Dantrolene can cause liver damage — and this is the number one safety concern with long-term use. Regular blood tests (liver function tests) are the only way to catch a problem ear...
📖 Read our full Dantrolene guide →

🕸️ Concept Web — How Dantrolene sodium 0.333 MG/ML Injectable Solutio... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dantrolene sodium 0.333 MG/ML Injectable Solution [Revonto] RxCUI 1012465

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dantrolene 3105
    • Dantrolene sodium 3106
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Revonto 1012462
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dantrolene Injectable Solution 377095
    • Dantrolene sodium Injectable Solution 2646074
    • Dantrolene Injectable Product 1151848
    • Dantrolene sodium Injectable Product 2662061
    • Dantrolene Injectable Solution [Revonto] 1012464
    • Dantrolene sodium Injectable Solution [Revonto] 2657925
    • Revonto Injectable Product 1183045
    • Injectable Solution 316949
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dantrolene sodium 0.333 MG/ML Injectable Solution SCD · 856696
  • Dantrolene sodium 0.333 MG/ML SCDC · 856695
  • Dantrolene Injectable Solution SCDF · 377095
  • Dantrolene sodium Injectable Solution SCDFP · 2646074
  • Dantrolene Injectable Product SCDG · 1151848
  • Dantrolene sodium Injectable Product SCDGP · 2662061

Brand-Name Concepts

  • Dantrolene sodium 0.333 MG/ML [Revonto] SBDC · 1012463
  • Dantrolene Injectable Solution [Revonto] SBDF · 1012464
  • Dantrolene sodium Injectable Solution [Revonto] SBDFP · 2657925
  • Revonto Injectable Product SBDG · 1183045
  • Revonto BN · 1012462

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1012465 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
78670-0003-67 6 VIAL, GLASS in 1 CARTON (78670-003-67) / 60 mL in 1 VIAL,... Revonto USWM, LLC 2021-04-09
84549-0003-67 60 mL in 1 VIAL, GLASS (84549-003-67) Revonto ProPharma Distribution 2025-09-15
Observed labelers: ProPharma Distribution (1) · USWM, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.